Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

096760.KS

Strong BuyFull HouseREMOVE

JW Holdings Corporation · Healthcare · South Korea · $209M · Avg Vol: $338K/d

100
StockRank
Get insider-trade alerts
Q
75
V
94
M
70
P/E (TTM)
5.0x
ROE
26.8%
D/E
0.6x
Dividend %
5.1%
Dir. Trades · 180d
None →
Subst. holders: +$701.9K
Buybacks · 180d
None →
AI CONVICTION THESIS

While the firm has insider buying, the information provided is insufficient to justify an asymmetric thesis; the Healthcare sector at this valuation requires clearer links to the GLP-1 pivot or defensive moat performance, which are absent here.

COMPANY DESCRIPTION

JW Holdings Corporation is the holding company for the JW Group, overseeing a portfolio of healthcare subsidiaries specialized in pharmaceuticals, medical devices, and diagnostics. Through its key operating units, the company commands a dominant, near-monopoly position in South Korea's essential intravenous (IV) fluid market. It leverages a vertically integrated business model to drive synergies across drug discovery, manufacturing, and global distribution.

FINANCIAL SUMMARY (KRW)

Year2022202320242025CAGRTTM
Revenue864.5B928.1B887.7B969.6B3.9%1.0T
EPS (KRW)306.49265.00874.00841.0040.0%835.63
Shares72.3M70.8M70.7M69.2M-4.3%69.2M
Debt552.0B554.6B435.9B359.6B-13.3%354.8B
Equity107.0B124.0B229.5B267.0B35.6%—
Op CF104.4B112.3B97.9B163.7B16.2%206.7B
Inv CF-107.0B-69.2B17.7B-24.7B——
Fin CF16.8B-29.1B-141.4B-111.5B——
Loading 1Y...
PRICE (1Y)+8.2%
2.672.802.923.053.18Jul 28Aug 19Sep 9
SMA 50SMA 200

Close
$3.10
RSI (14)
61.2
52W High
$3.52
From 52W High
0.9%

SCORE BREAKDOWN

Quality
75
ROIC
21.2%92.3
ROE
26.8%93.7
GP/Assets
47.8%85.4
Op. Margin
20.2%84.2
FCF/Assets
9.4%85.7
Piotroski
784.3
Int. Cover
8.3x60.8
D/E Ratio
0.55x28.1
Current Ratio
0.80x5.7
Value
94
P/E (TTM)
5.0x97.6
EV/EBITDA
3.9x94.7
P/FCF
2.7x97.0
P/B
1.1x82.3
P/S
0.3x96.4
Div Yield
5.1%89.9
Momentum
70
52W High %
88%82.7
RS 6M
-10%45.0
SMA 50/200
1.03x65.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
384%96.0

FUNDAMENTALS

Market Cap
$209M
P/E (Forward)
—
Gross Margin
51.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 096760.KS are excluded.

TickerCompanyMkt CapStockRankSignal
096760.KSJW Holdings Corporation(you)$209M100Strong Buy
005500.KSSamjin Pharmaceuticals Co., Ltd.$170M93Strong Buy
033270.KSKorea United Pharm Inc.$188M88Strong Buy
016580.KSWhan In Pharm Co.,Ltd.$137M94Strong Buy
234080.KSJW Lifescience Corporation$128M93Strong Buy
001540.KQAhn-Gook Pharmaceutical Co., Ltd.$91M100Strong Buy
023910.KQDaihan Pharmaceutical Co.,Ltd.$116M90Strong Buy
001630.KSChong Kun Dang Holdings Corp.$136M86Strong Buy
008490.KSSuheung Co., Ltd.$186M80Buy
001060.KSJW Pharmaceutical Corporation$461M92Strong Buy

Peer medians: ROE -0.3% · P/E 16.2x · Gross margin 43.0%

JW Holdings Corporation (096760.KS): Stock Score Summary

JW Holdings Corporation (096760.KS) has a MoatMap StockRank of 100/100 based on Quality (75/100), Value (94/100), and Momentum (70/100) factor scores. The current signal is STRONG BUY. While the firm has insider buying, the information provided is insufficient to justify an asymmetric thesis; the Healthcare sector at this valuation requires clearer links to the GLP-1 pivot or defensive moat performance, which are absent here.

JW Holdings Corporation is the holding company for the JW Group, overseeing a portfolio of healthcare subsidiaries specialized in pharmaceuticals, medical devices, and diagnostics. Through its key operating units, the company commands a dominant, near-monopoly position in South Korea's essential intravenous (IV) fluid market. It leverages a vertically integrated business model to drive synergies across drug discovery, manufacturing, and global distribution.

Key Financial Metrics

Price$3.10
Market Cap$209M
P/E (TTM)4.99
Price/Book1.09
Return on Equity26.8%
Return on Invested Capital21.2%
Debt/Equity0.55x
Gross Margin51.7%
Operating Margin20.2%
Revenue Growth16.7%
Dividend Yield5.1%
Free Cash Flow$76M

JW Holdings Corporation operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is JW Holdings Corporation’s (096760.KS) StockRank?
MoatMap’s StockRank for JW Holdings Corporation (096760.KS) is 100/100, with a Strong Buy signal. It is a composite of Quality (75), Value (94), and Momentum (70) factor ranks across MoatMap’s 20,000+ stock universe.
Does JW Holdings Corporation have an economic moat?
JW Holdings Corporation (096760.KS) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is JW Holdings Corporation a buy, hold, or sell?
MoatMap’s current signal for JW Holdings Corporation (096760.KS) is Strong Buy, based on a StockRank of 100/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is JW Holdings Corporation in?
JW Holdings Corporation (096760.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks096760.KS deep dive reportAI ChampionsHow we score stocksSense-check another stock